Monday on the RealClearPolitics podcast, Tom Bevan, Andrew Walworth, and Carl Cannon discussed the return of celebrity ...
President Trump was recently spotted with a prominent blue bruise on his hand, sparking widespread speculation. While minor ...
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2026 Earnings Call Transcript February 3, 2026 Operator: Good day, everyone. And ...
Euthanasia protocols rely on off-label drugs. With little data and no oversight on complications, how do we know the death is ...
Each Olympic cycle, athletes and support staff chase the latest cutting-edge knowledge in pursuit of Gold. In the Winter ...
ORLANDO, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation’s leading compounding pharmacies, are proud to announce that their Chief Executive Officer, Mark ...
Each day, Trump proves he is an embarrassment to The United States. His behavior, comments, actions show just how disgusting ...
Journalist Brian Goldstone argues that homelessness in America is not primarily caused by joblessness or individual ...
California's housing crisis is being driven by political hesitation, outdated zoning choices, and a regulatory and fiscal ...
While Boomers see their decades of experience as automatic credentials for deference, Gen Z workers are quietly revolutionizing workplace dynamics by treating respect as something proven through ...
Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease In the LEAP2MONO phase 3 study, venglustat, dosed orally once daily, demonstrated clinically meaningful ...
Sanofi’s LEAP2MONO phase 3 study of venglustat to treat type 3 Gaucher disease meets all primary endpoints: Paris Tuesday, February 3, 2026, 13:00 Hrs [IST] Positive results fro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results